Efficacy, Durability, and Safety of Intravitreal Faricimab up to Every 16 Weeks for Neovascular Age-Related Macular Degeneration (Tenaya and Lucerne): Two Randomised, Double-Masked, Phase 3, Non-Inferiority Trials

AuthID
 P-013-TKR
100
Author(s)
Heier J.S.
·
Khanani A.M.
·
Quezada Ruiz C.
·
Basu K.
·
Ferrone P.J.
·
Ferrone P.J.
·
Brittain C.
·
Figueroa M.S.
·
Figueroa M.S.
·
Lin H.
·
[+45]·
[+35]·
Fine H.
·
Fineman M.
·
Fox G.M.
·
Francais C.
·
Franco P.
·
Fraser-Bell S.
·
Fung N.
·
Furno Sola F.
·
Gale R.
View all authors
Tipo de Documento
Article
Year published
2022
Publicado
in The Lancet, ISSN: 0140-6736
Volume: 399, Número: 10326, Páginas: 729-740 (11)
Indexing
Scopus®
Crossref®258
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 35085502
SCOPUS: 2-s2.0-85124671320
Source Identifiers
ISSN: 0140-6736
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.
All authors
Name Order Nome   Name Order Nome   Name Order Nome
1 Heier J.S.;   2 Khanani A.M.;   3 Quezada Ruiz C.;
4 Basu K.;   5 Ferrone P.J.;   6 Ferrone P.J.;
7 Brittain C.;   8 Figueroa M.S.;   9 Figueroa M.S.;
10 Lin H.;   11 Holz F.G.;   12 Patel V.;
13 Lai T.Y.Y.;   14 Silverman D.;   15 Regillo C.;
16 Swaminathan B.;   17 Viola F.;   18 Cheung C.M.G.;
19 Wong T.Y.;   20 Abbey A.;   21 Abdulaeva E.;
22 Abraham P.;   23 Adan Civera A.;   24 Agostini H.;
25 Alezzandrini A.;   26 Alfaro V.;   27 Almony A.;
28 Altay L.;   29 Amini P.;   30 Antoszyk A.;
31 Aradi E.;   32 Arias L.;   33 Arnold J.;
34 Asaria R.;   35 Astakhov S.;   36 Astakhov Y.;
37 Awh C.C.;   38 Balaratnasingam C.;   39 Banerjee S.;
40 Baumal C.;   41 Becker M.;   42 Belfort R.;
43 Bratko G.;   44 Bridges W.Z.;   45 Brown J.;
46 Brown D.M.;   47 Budzinskaya M.;   48 Buffet S.;
49 Burgess S.;   50 Byon I.;   51 Cagini C.;
52 Calzada J.;   53 Cameron S.;   54 Campochiaro P.;
55 Carlson J.;   56 Carneiro A. ;   57 Chan C.;
58 Chang E.;   59 Chang A.;   60 Chao D.;
61 Chaudhry N.;   62 Chee C.;   63 Cheek A.;
64 Chen S.J.;   65 Chen S.N.;   66 Cheung G.;
67 Chexal S.;   68 Chittum M.;   69 Chow D.;
70 Cole A.;   71 Connolly B.;   72 Cornut P.L.;
73 Couvillion S.;   74 Danzig C.;   75 Daskalov V.;
76 Dessouki A.;   77 Devin F.;   78 Dollin M.;
79 Dolz R.;   80 Downey L.;   81 Dreyer R.;
82 Dugel P.;   83 Eichenbaum D.;   84 Eldem B.;
85 Engstrom R.;   86 Escobar J.J.;   87 Eter N.;
88 Faber D.W.;   89 Falk N.;   90 Feiner L.;
91 Figueroa M.;   92 Fine H.;   93 Fineman M.;
94 Fox G.M.;   95 Francais C.;   96 Franco P.;
97 Fraser-Bell S.;   98 Fung N.;   99 Furno Sola F.;
100 Gale R.;    

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service